NEUPATH HEALTH REPORTS THIRD QUARTER 2025 RESULTS
Third quarter total revenue of $22.1 million, up 26% year-over-year Positive cash flows, with Adjusted EBITDA(1) of $1.5 million, up 98% year-over-year, and our 27th consecutive quarter of positive Adjusted EBITDA Investor webinar scheduled for Thursday, Nove
(Financial Post, 2025-11-13T12:37:26Z)